Hypothyroidism-induced kidney dysfunction: an under-recognized phenomenon in patients on immune checkpoint inhibitors

Author:

Tan Hui Zhuan1ORCID,Zhu Ling2,Chan Jack Junjie3,Rajasekaran Tanujaa D/O3,Choo Jason Chon Jun1

Affiliation:

1. Department of Renal Medicine, Singapore General Hospital , Central Region, Singapore

2. Department of Endocrinology, Singapore General Hospital , Central Region, Singapore

3. Department of Medical Oncology, National Cancer Centre Singapore , Singapore

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Reference7 articles.

1. Checkpoint inhibitor therapy-associated acute kidney injury: time to move on to evidence-based recommendations;Perazella;Clin Kidney J,2021

2. Immune checkpoint inhibitor-induced thyroiditis is a risk factor for acute and chronic kidney dysfunction;Strohbehn;Nephrol Dial Transplant,2021

3. Pembrolizumab-induced hypothyroidism caused reversible increased serum creatinine levels: a case report;Matsuoka;BMC Nephrology,2020

4. The renal manifestations of thyroid disease;Mariani;J Am Soc Nephrol,2012

5. C-reactive protein as a biomarker for immune-related adverse events in melanoma patients treated with immune checkpoint inhibitors in the adjuvant setting;Lauwyck;Melanoma Res,2021

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3